Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation

Published:2015-08 Issue:8 Volume:21 Page:1392-1398
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Ciurea Stefan O.,Thall Peter F.,Milton Denái R.,Barnes Titus H.,Kongtim Piyanuch,Carmazzi Yudith,López Asdrúbal A.,Yap Dianne Y.,Popat Uday,Rondon Gabriela,Lichtiger Benjamin,Aung Fleur,Afshar-Kharghan Vahid,Ma Qing,Fernández-Viña Marcelo,Champlin Richard E.,Cao Kai

Funder

University of Texas MD Anderson Cancer Center

MDACC research fund

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference33 articles.

1. Significance of the positive crossmatch test in kidney transplantation;Patel;N Engl J Med,1969

2. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma;Anasetti;N Engl J Med,1989

3. Anti-HLA antibodies after solid organ transplantation;McKenna;Transplantation,2000

4. Donor-specific anti-HLA antibody monitoring and removal in solid organ transplant recipients;Everly;Clin Transpl,2011

5. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation;Ciurea;Transplantation,2009

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Desensitization with daratumumab in a pediatric patient with thalassemia major and high donor‐specific antibody prior to haploidentical transplantation;Pediatric Blood & Cancer;2024-09-03

2. Impaired survival of patients with non donor-specific anti-HLA antibodies before HLA-mismatched allogeneic stem cell transplantation;Current Research in Translational Medicine;2024-09

3. ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA Antibodies;Transplantation and Cellular Therapy;2024-09

4. Uniform graft-versus-host disease prophylaxis using post-transplantation cyclophosphamide, methotrexate, and cyclosporine following peripheral blood hematopoietic stem cell transplantation from matched and haploidentical donors for transfusion-dependent thalassemia: a retrospective report from the BMF-WG of Hunan province, China;Transplantation and Cellular Therapy;2024-09

5. Relevance of donor-specific HLA antibodies in hematopoietic cell transplantation;Best Practice & Research Clinical Haematology;2024-09